Equity Overview
Price & Market Data
Price: $0.781
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $4,569,662
Volume: 0
Performance Metrics
1 Week: -3.54%
1 Month: -12.81%
3 Months: 0.19%
6 Months: 2.20%
1 Year: -65.90%
YTD: -21.10%
Details
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.